When was Factor Bioscience founded?

Factor Bioscience was founded in 2011 and raised its 1st funding round 1 year after it was founded.

Where is Factor Bioscience located?

Factor Bioscience is headquartered in Cambridge, United States.

How many employees does Factor Bioscience have?

As of Sep 30, 2026, the latest employee count at Factor Bioscience is 12.

Is Factor Bioscience a funded company?

Factor Bioscience is a funded company, having raised a total of $1M across 5 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Sep 17, 2012.

When was the latest funding round of Factor Bioscience?

Factor Bioscience's latest funding was a $***** Seed round on Sep 15, 2025, with participation from 0 investor.

Where does Factor Bioscience rank among its competitors?

Factor Bioscience ranks 13th amongst 144 active competitors, of which 48 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Senti Bio, which secured $40M in May, 2026.

Who are the top competitors of Factor Bioscience?

Factor Bioscience's top competitors include Senti Bio, Illumina and Bluebird Bio. Among them, Senti Bio secured the most recent funding round in May, 2026.

Factor Bioscience - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of genomic technologies to treat disease and improve health. The company's gene-editing and cell-reprogramming technologies enable the generation of clonal lines of pluripotent stem cells development of regenerative cell therapies. Also, it has developed disease-focused technologies to create treatments for cancer, genetic, infectious, and degenerative diseases.

Website: factor.bio
Social
Email ID: *****@factorbio.com
Part Of

Key Metrics

Founded Year

2011

Location

Cambridge, United States

Stage

Seed

Total Funding

$1M in 5 rounds

Latest Funding Round

Seed, Sep 15, 2025, $*****

Investors

Military Health & 2 more

Ranked

13^th among 144 active competitors

Employee Count

12 as on Sep 30, 2026

Similar Companies

Senti Bio & 165 more

View Factor Bioscience's full profile

Factor Bioscience has raised a total funding of $1M over 5 rounds. Its first funding round was on Sep 17, 2012. Factor Bioscience has 3 institutional investors.

Here is the list of recent funding rounds of Factor Bioscience:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 15, 2025	7440478	Seed	4176172	9877603	9708471	7807652
Jul 09, 2025	5205627	Grant (prize money)	8309567	2101042	5958172	Military Health
Sep 17, 2013	5694929	Grant (prize money)	2785896	9271022	1798375	SBIR

Access funding benchmarks and valuations. Sign up today!

View details of Factor Bioscience's funding rounds and investors

The founders of Factor Bioscience is Christopher Rohde.

Here are the details of Factor Bioscience's key team members:

Christopher Rohde: Co-Founder & CTO of Factor Bioscience and founder of 2 other companies, Novellus and Factor Bioscience. They serve on the board of 1 company.

View details of Factor Bioscience's Founder profiles and Board Members

Factor Bioscience's employee count trend

Factor Bioscience has 12 employees as of Sep 26. Here is Factor Bioscience's employee count trend over the years:

Employee count trend for Factor Bioscience

Uncover Factor Bioscience's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Factor Bioscience include Senti Bio, Illumina and Bluebird Bio. Here is the list of Top 10 competitors of Factor Bioscience, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Senti Bio 2016, San Francisco (United States), Public	Developer of cell and gene therapies for patients living with incurable diseases	$158M	Leaps by Bayer, New Enterprise Associates ... & 30 others	72/100
2nd	Illumina 1993, San Diego (United States), Public	Developer of technologies for analysis of genetic variation and function	$28M	Chevron Technology Ventures, Dow Chemical Company ... & 32 others	71/100
3rd	Bluebird Bio 1992, Cambridge (United States), Acquired	Developer of gene therapies for severe genetic and rare diseases	$136M	TVM Capital, Forbion & 10 others	70/100
4th	Tenaya Therapeutics 2016, San Francisco (United States), Public	Developer of regenerative and gene therapeutics for heart failure	$248M	RTW Investments, Fidelity Investments & 7 others	70/100
5th	ImmunoACT 2018, Mumbai (India), Series B	Developer of cell and gene therapies for cancer treatment	$15.9M	SINE, Laurus Labs & 4 others	67/100
6th	Arbor Biotechnologies 2016, Cambridge (United States), Series C	Provider of genomic technologies and drug discovery platform	$304M	TCG Crossover, Temasek & 27 others	64/100
7th	MGI 2016, Shenzhen (China), Series B	Provider of gene sequencing instruments, reagents, equipment, and related products	$1B	Guotai Junan Securities, CoStone Capital ... & 13 others	63/100
8th	Nuevocor 2021, Singapore (Singapore), Series B	Developer of genetic medicines for treating rare heart muscle conditions	$80.6M	Kurma Partners, Boehringer Ingelheim Venture Fund ... & 7 others	62/100
9th	Eclipse Bio 2017, San Diego (United States), Series A	Developer of cell-free immunoassay	$18.9M	Alexandria, IGlobe Partners & 2 others	61/100
10th	Spur Therapeutics 2015, Stevenage (United Kingdom), Acquired	Developer of gene therapies for debilitating chronic diseases	$274M	Syncona, Wellington & 8 others	61/100
13th	Factor Bioscience 2011, Cambridge (United States), Seed	Developer of genomic technologies to treat disease and improve health	$1M	Military Health, SBIR & 1 others	55/100